Sentinels / Actor desk
Biocon Group
organization · Registry status: unverified
d1b1fbea-d98c-51be-998a-e306352f09df
Evidence, not intent.
Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.
No claim of complete coverage or live monitoring.
Observation window
UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.
Recent observations / timeline
The source record
85 distinct events shown, newest first. Headlines may be generated summaries; inspect the source before repeating a claim.
NCLT declares Videocon's Venugopal Dhoot bankrupt; SBI to recover Rs 12,668 crore
aol.com: Pacira Biosciences, Pacira Biosciences, Pacira Biosciences (wb 1358 generic drugs, wb 1358 generic drugs)
Viatris Reports Third-Quarter 2026 Financial Results
moneycontrol.com: Donald Trump, Tata Elxsi, Great Eastern Shipping Company (wb 508 power systems, wb 507 energy and extractives)
Pills are paying off! Pharma stocks lead 2026 rally with up to 112% return
business-standard.com: Biocon Biosimilars, Kiran Mazumdar-Shaw, Biocon (tax fncact executive, science)
Stock Market Today Live: Sensex zooms 1,400 pts, Nifty tops 24,300 on strong global cues
Biocon's Q2 net profit plunges 57% to Rs 56.7 cr; biosimilars launch to fuel stronger H2
SEBI forms 18-member working group to review listing framework for deep-tech, innovation-led startups
Q2 Results Today Highlights: BSE, Apollo Hospitals, Sundaram Finance post higher profit in Q2; Biocon, Zydus Life profit declines
moneycontrol.com: Shreehas Tambe, Genentech, Biocon (tax military title officer, tax fncact officer)
aninews.in: Siddharth Pai, Naganand Doraswamy, Srini Srinivasan (tax worldlanguages bharat, uspec politics general1)
SEBI forms 18-member working group to review listing framework for deep-tech, innovation-led startups
Biocon forecasts stronger second half of FY27 with multiple growth drivers despite Q2 profit decline
business-standard.com: Shreehas Tambe, Biocon, Biocon
Biocon Q2 PAT drops 51% as Syngene weakness weighs on earnings
BioMar reports ‘exceptional earnings’ in Q3
India’s IPO boom faces a reality check as investors no longer buy every story | Stock Market News
Biocon Malaysia Recognised Across Five Categories at MOPI Pharma Industry Awards 2026
business-standard.com: Zydus Lifesciences, Max Enviro, Aurobindo Pharma (wb 175 fertilizers, wb 174 crop production)
business-standard.com: Chemplast Sanmar, Marksans Pharma, Lal Pathlabs (wb 1331 health technologies, wb 1350 pharmaceuticals)
moneycontrol.com: Anupama Kothari, Lal Pathlabs, Carver Roboweld (epu cats healthcare, epu economy historic)
Stocks in news: NSE, BSE, SBI, Happiest Minds, MCX, IEX and Minda Corp
Ahead of Market: 10 things that will decide stock market action on Wednesday
Muhurat Trading Picks: Adani Ports, Info Edge to Kotak Bank - ICICI Sec recommends these 10 stocks to buy on Diwali | Stock Market News
Stock Market Highlights, Nov 3: Sensex jumps 1,225 pts at close, Nifty crosses 23,800; indices rise for 4th straight session
moneycontrol.com: Indian Cros, Kiran Mazumdar-Shaw, Siddharth Mittal (tax fncact ceo, tax fncact ceo)
India 2030: Who Supplies the Next 10 Million?
business-standard.com: Sun Pharma, Mandar Ghatnekar, Tejomay Pandya (epu policy regulatory, epu policy regulatory)
Lab Rats series: Activating ‘natural killers’ for cancer with Zumutor | Company Business News
moneycontrol.com: Amit Bakshi, Amit Bakshi, Amit Bakshi (wb 1331 health technologies, wb 1331 health technologies)
New Research Aims to Improve Lives of Prostate Cancer Survivors
Biocon Named Among Science Magazine’s Best Employers in Global Biotech and Pharma for 2026
NDTV Profit Reports Mixed Recommendations on Six Indian Stocks | EconoTimes
Stock Market Today Highlights, October 26: Stock markets rebound after 4-day slump; Sensex jumps 483 points
business-standard.com: Johnson Johnson Janssen, Janssen Sciences Ireland, Biocon (tax disease diseases, wb 1406 diseases)
Biocon’s Pertuzumab Biosimilar Receives Positive CHMP Opinion Under EMA’s Tailored Clinical Approach
moneycontrol.com: Biocon, Fortis, Fortis (wb 698 trade, ungp forests rivers oceans)
IIT Madras launches UDYOG finishing school to make biotechnology graduates industry-ready; First batch from January 18 - The Times of India
Boisson Foundry Chooses Koyama 400Si – Automation as an Answer to the Skilled Labour Challenge
Medical Health & Life Science Research News
Form 8.3 - Brave Bison Group Plc
Disclosure Table | Company Announcement | Investegate
business-standard.com: Vishal Mega Mart, National Stock Exchange, Apar Industries (epu cats migration fear fear, tax fncact investor)
BioMar targets nutrient retention with new formulation concept
Posting of Second Response Document | Company Announcement | Investegate
What are the details of the government’s sale of IDBI | Explained
Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launch
Tycoons Amplify Calls For Stronger AI Rules As Risks Mount - News India Times
Biocon clears path for cancer drug launch
Publication & Posting Of Shareholder Communication | Company Announcement | Investegate
Biocon Secures Earliest Licensed Launch Dates for Pebrilzo® (bPertuzumab) Following Global Patent Settlement with Genentech
Biocon gets launch clarity for breast cancer biosimilar after Genentech deal
Nifty, Sensex End Lower as Crude Nears $106, Foreign Investor Selling Weighs– Wednesday Closing Report
IDBI Bank's bad loan legacy: Kingfisher, ABG Shipyard exposures highlight lending risks - BusinessToday
Stock Market Today Highlights, Oct 14: Sensex falls 252 points, Nifty slips to 22,622, as rising crude, FII selling weigh on markets
Biocon inks global patent settlement pact with Genentech for breast cancer drug Pebrilzo
moneycontrol.com: Perjeta Pertuzumab, Biocon Ltd On, European Union (tax disease disease, ungp healthcare)
moneycontrol.com: Sun Pharma, Sun Pharma, Sun Pharma (wb 2453 organized crime, wb 2433 conflict and violence)
AI cannot replace clinical trials soon, warns Moderna co-founder Noubar Afeyan
business-standard.com: Henlius Biologics, Genentech, Genentech (ungp forests rivers oceans, wb 2081 financial disclosure)
Can AI help India move beyond manufacturing to drug innovation?
Who is BR Shetty? Why did UAE businessman seek $15 billion from Bank of Baroda? What is driving the news? Explained | Mint
Digital skills development of South Asian women entrepreneurs: Opportunities and challenges for Sri Lanka | Daily FT
chinanationalnews.com: Syngene International Executive Chairperson Kiran Mazumdar-Shaw, Indian Foundation For Quality Management, United States (tax ethnicity indian, tax fncact chairperson)
PumpkinMania returns to Transylvania Oct. 25 for 16th year
beijingbulletin.com: United States, Indian Foundation For Quality Management, Syngene International Executive Chairperson Kiran Mazumdar-Shaw (tax fncact leaders, wb 1921 private sector development)
India must shift pharma industry from generics to innovation-led growth: Kiran Mazumdar-Shaw
Form 8.3 - Brave Bison Group Plc
BI Group teams up with Citic Contracting for prime Dubai projects
BI Group teams up with Citic Contracting for prime Dubai projects
India must shift pharma industry from generics to innovation-led growth: Kiran Mazumdar-Shaw
sydneysun.com: Syngene International Executive Chairperson Kiran Mazumdar-Shaw, United States, Indian Foundation For Quality Management (epu policy regulatory, epu policy regulatory)
australianherald.com: United States, Syngene International Executive Chairperson Kiran Mazumdar-Shaw, Indian Foundation For Quality Management (epu policy regulatory, epu policy regulatory)
India must shift pharma industry from generics to innovation-led growth: Kiran Mazumdar-Shaw
Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growth
India must shift pharma industry from generics to innovation-led growth: Kiran Mazumdar-Shaw
webindia123.com: Indian Foundation For Quality Management, Biocon, United States (wb 566 environment and natural resources, wb 566 environment and natural resources)
India must shift pharma industry from generics to innovation-led growth: Kiran Mazumdar-Shaw
aninews.in: Biocon, Biocon, United States (wb 1331 health technologies, wb 1358 generic drugs)
IRCON Bags ₹862.46 Crore Railway Contract, East Central Railway Awards Major Track Expansion Project
HSBC emerges as top international bank for Indian corporate fundraising
October 12: Two dozen stocks, including Lenskart, Everyday Ind, SJS, Authum, Chemplast, Bajel Projects will remain in focus
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw
AI’s growing risks: from economic shock to loss of human control - Shafaqna English | International Shia News & Fatwas
Signals to inspect
Anomalies
Latest 10 in the selected window (up to 10). Detector output, not verified conclusions.
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
New connection: 4 previously unseen co-actor(s) detected (known network: 435)
Tone shift: score -4.3 deviates 3.0σ from baseline mean 2.7 (stddev 2.38)
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
New connection: 25 previously unseen co-actor(s) detected (known network: 426)
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
New connection: 14 previously unseen co-actor(s) detected (known network: 412)
New connection: 16 previously unseen co-actor(s) detected (known network: 401)
New connection: 1 previously unseen co-actor(s) detected (known network: 400)
Narrative context
Unresolved threads
Latest 20 at most, across all dates. Stored narratives require human review.
Stored connections
Relationships
Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.
- United States Senate→ co mention →Biocon Group127 evidence records
- Zydus Lifesceices→ co mention →Biocon Group72 evidence records
- Aurobindo Pharma→ co mention →Biocon Group72 evidence records
- Biocon Group→ co mention →Cipla68 evidence records
- Biocon Group→ co mention →Kiran Mazumdar-Shawshe65 evidence records
- Biocon Group→ co mention →Shreehas Tambe62 evidence records
- Biocon Biologics→ co mention →Biocon Group51 evidence records
- Fosun Pharma→ co mention →Biocon Group51 evidence records
- International Law→ co mention →Biocon Group51 evidence records
- Nasdaq→ co mention →Biocon Group49 evidence records
- Donald Trump→ co mention →Biocon Group47 evidence records
- Sun Pharmaceuticals On→ co mention →Biocon Group46 evidence records
- Claire→ co mention →Biocon Group44 evidence records
- Biocon Group→ co mention →More Teva Pharmaceutical Industries News41 evidence records
- Piramal Pharma→ co mention →Biocon Group39 evidence records
- Biocon Group→ co mention →Smita Mazumdar36 evidence records
- Reuters→ co mention →Biocon Group35 evidence records
- M Shaifur Rahman Mazumdar→ co mention →Biocon Group34 evidence records
- Reliance Industries→ co mention →Biocon Group31 evidence records
- Drug Enforcement Administration→ co mention →Biocon Group31 evidence records
- Pfizer→ co mention →Biocon Group31 evidence records
- Union Budget→ co mention →Biocon Group29 evidence records
- Infosys→ co mention →Biocon Group29 evidence records
- Wipro→ co mention →Biocon Group26 evidence records
- Organon Co→ co mention →Biocon Group26 evidence records
- Glenmark Pharmaceuticals Inc United States→ co mention →Biocon Group25 evidence records
- Biocon Group→ co mention →Eli Lilly25 evidence records
- Viksit Bharat→ co mention →Biocon Group24 evidence records
- Reddy Laboratories Limited On→ co mention →Biocon Group24 evidence records
- Biocon Group→ co mention →Novo Nordisk24 evidence records
- Ather Energy→ co mention →Biocon Group24 evidence records
- National Stock Exchange→ co mention →Biocon Group23 evidence records
- Regulatory Information Service The Pricing Announcement→ co mention →Biocon Group23 evidence records
- Nirmala Sitharaman→ co mention →Biocon Group23 evidence records
- Biocon Group→ co mention →Digital Aviation Solutions22 evidence records
- Miniso Group→ co mention →Biocon Group22 evidence records
- Biopharma Shakti→ co mention →Biocon Group22 evidence records
- Susquehanna International Group→ co mention →Biocon Group22 evidence records
- Larsen Toubro→ co mention →Biocon Group22 evidence records
- Read Adani Enterprises→ co mention →Biocon Group22 evidence records
- Biocon Group→ co mention →Siddharth Dungarwal22 evidence records
- Representative Of Toscafund Asset Management→ co mention →Biocon Group21 evidence records
- Nextenergy Solar Fund Limited Red→ co mention →Biocon Group21 evidence records
- Mara Bidco Ltd→ co mention →Biocon Group21 evidence records
- Frankel United Kingdom Bidco Limited→ co mention →Biocon Group21 evidence records
- Biocon Group→ co mention →Tata Motor21 evidence records
- Jubilant Sykes→ co mention →Biocon Group21 evidence records
- Al Tadawi Healthcare Group→ co mention →Biocon Group21 evidence records
- Sensex Today Hindalco Industries→ co mention →Biocon Group21 evidence records
- Tate Lyle→ co mention →Biocon Group21 evidence records
Ask this desk
Desk analyst
Read-only questions about Biocon Group's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.
Operator sign-in is required. Sign in